Purpose Insomnia is problematic for older adults. After behavioral modifications fail to show
adequate response, pharmacologic options are used. The pharmacokinetics of agents used …

Chronic insomnia affects 57% of the elderly in the United States, with impairment of quality
of life, function, and health. Chronic insomnia burdens society with billions of dollars in direct …

BACKGROUND:: Chronic insomnia is common among the elderly These elderly patients are
often viewed as difficult to treat, yet they are among the groups with the greatest need of …

Insomnia is commonly seen in elderly populations and is associated with numerous
individual and socioeconomic consequences. Elderly patients are more likely to suffer from …

Purpose Insomnia is highly prevalent in older persons and significantly impacts quality of
life, functional abilities, and health status. It is frequently treated with benzodiazepines or Z …

Background: Insomnia remains one of the most common sleep disorders encountered in the
geriatric clinic population, frequently characterized by the subjective complaint of difficulty …

Background. Although insomnia is highly prevalent, sleep disturbances often go
unrecognized and untreated. When insomnia is recognized, considerable emphasis has …

Although the GABAergic benzodiazepines (BZDs) and Z-drugs (zolpidem, zopiclone, and
zaleplon) are FDA-approved for insomnia disorders with a strong evidence base, they have …

Insomnia accounts for more than 5.5 million visits to family physicians each year. Although
behavioral interventions are the mainstay of treatment, pharmacologic therapy may be …

Introduction: Sleep is a vital neurochemical process involving sleep-promoting and arousal
centers in the brain. Insomnia is a pervasive disorder characterized by difficulties in initiating …